These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25069996)

  • 1. Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO).
    Margiotta N; Denora N; Piccinonna S; Laquintana V; Lasorsa FM; Franco M; Natile G
    Dalton Trans; 2014 Nov; 43(43):16252-64. PubMed ID: 25069996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand.
    Denora N; Margiotta N; Laquintana V; Lopedota A; Cutrignelli A; Losacco M; Franco M; Natile G
    ACS Med Chem Lett; 2014 Jun; 5(6):685-9. PubMed ID: 24944744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum(II) complexes with bioactive carrier ligands having high affinity for the translocator protein.
    Margiotta N; Denora N; Ostuni R; Laquintana V; Anderson A; Johnson SW; Trapani G; Natile G
    J Med Chem; 2010 Jul; 53(14):5144-54. PubMed ID: 20568783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of Tricarbonyl (99m)Tc-Labeled 2-(4-Chloro)phenyl-imidazo[1,2-a]pyridine Analogs as Novel SPECT Imaging Radiotracer for TSPO-Rich Cancer.
    Choi JY; Iacobazzi RM; Perrone M; Margiotta N; Cutrignelli A; Jung JH; Park do D; Moon BS; Denora N; Kim SE; Lee BC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.
    Savino S; Denora N; Iacobazzi RM; Porcelli L; Azzariti A; Natile G; Margiotta N
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO).
    Piccinonna S; Margiotta N; Denora N; Iacobazzi RM; Pacifico C; Trapani G; Natile G
    Dalton Trans; 2013 Jul; 42(28):10112-5. PubMed ID: 23752769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels.
    Lopalco A; Cutrignelli A; Denora N; Perrone M; Iacobazzi RM; Fanizza E; Lopedota A; Depalo N; de Candia M; Franco M; Laquintana V
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tautomerization of 2-nitroso-N-arylanilines by coordination as N,N'-chelate ligands to rhenium(I) complexes and the anticancer activity of newly synthesized oximine rhenium(I) complexes against human melanoma and leukemia cells in vitro.
    Wirth S; Wallek AU; Zernickel A; Feil F; Sztiller-Sikorska M; Lesiak-Mieczkowska K; Bräuchle C; Lorenz IP; Czyz M
    J Inorg Biochem; 2010 Jul; 104(7):774-89. PubMed ID: 20421133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxicity and cellular uptake studies of N3 functionalized Re(CO)3 thymidine complexes.
    Bartholomä MD; Vortherms AR; Hillier S; Joyal J; Babich J; Doyle RP; Zubieta J
    Dalton Trans; 2011 Jun; 40(23):6216-25. PubMed ID: 21369609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization.
    Taliani S; Da Pozzo E; Bellandi M; Bendinelli S; Pugliesi I; Simorini F; La Motta C; Salerno S; Marini AM; Da Settimo F; Cosimelli B; Greco G; Novellino E; Martini C
    J Med Chem; 2010 May; 53(10):4085-93. PubMed ID: 20438080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer.
    Denora N; Laquintana V; Lopalco A; Iacobazzi RM; Lopedota A; Cutrignelli A; Iacobellis G; Annese C; Cascione M; Leporatti S; Franco M
    J Control Release; 2013 Dec; 172(3):1111-25. PubMed ID: 24096015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of a Novel
    Liu P; Wang T; Yang R; Dong W; Wang Q; Guo Z; Ma C; Wang W; Li H; Su X
    ACS Omega; 2020 Dec; 5(49):31657-31664. PubMed ID: 33344817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly selective luminescent nanostructures for mitochondrial imaging and targeting.
    Fanizza E; Iacobazzi RM; Laquintana V; Valente G; Caliandro G; Striccoli M; Agostiano A; Cutrignelli A; Lopedota A; Curri ML; Franco M; Depalo N; Denora N
    Nanoscale; 2016 Feb; 8(6):3350-61. PubMed ID: 26763470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donor-based platinum complexes as potential anticancer agents.
    Zhao J; Gou S; Sun Y; Yin R; Wang Z
    Chemistry; 2012 Nov; 18(45):14276-81. PubMed ID: 23015473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel conjugable translocator protein ligand labeled with a fluorescence dye for in vitro imaging.
    Bai M; Wyatt SK; Han Z; Papadopoulos V; Bornhop DJ
    Bioconjug Chem; 2007; 18(4):1118-22. PubMed ID: 17552492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation.
    Laquintana V; Denora N; Cutrignelli A; Perrone M; Iacobazzi RM; Annese C; Lopalco A; Lopedota AA; Franco M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.